Contact: Matthew Swayne
Caption: Tempol significantly reduced the weight gain of the mice compared to the group of mice that were not fed the drug. Andrew Patterson, assistant professor of molecular toxicology at Penn State, said the study indicates that the drug acts on the microbiome and may open up new pathways for medical treatments.
Credit: Patrick Mansell, Penn State
Usage Restrictions: non commercial use only
Related news release: Adjusting bacteria in intestines may lead to obesity treatments